SUBSCRIBE
SUBSCRIBE
News   Deals

Progenics Pharmaceuticals, Inc. Acquires Molecular Insight Pharmaceuticals, Inc. to Expand Oncology-Focused Pipeline

January 22, 2013 | 
1 min read
TARRYTOWN, N.Y., Jan. 22, 2013 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX) today announced that it has acquired Molecular Insight Pharmaceuticals, Inc., a clinical-stage private biotechnology company with a small molecule chemistry pipeline aimed at enhancing cancer treatment.
Mergers & acquisitions
MORE ON THIS TOPIC
Business and financial crisis vector concept with businessman falling down the hole. Symbol of market crash, recession, risk, bankruptcy and loss. Eps10 illustration.
Mergers & acquisitions
Kronos Accepts $35M Concentra Buyout as Walls Close In
May 2, 2025
 · 
2 min read
 · 
Annalee Armstrong
Creative design. Desperate employee, office worker standing near question mark symbolizing business struggles, options. Choosing strategy for achieving goal. Concept of business, career development
Earnings
Tariffs Keep Biogen Execs Busy in Q1 but Impacts Expected To Be Minimal
May 1, 2025
 · 
3 min read
 · 
Annalee Armstrong
Paying double wages or giving double money, greed and lust, double work for double wages, one person splitting into two and claiming both
Deals
Novartis Strikes on M&A, Leading a Line of Big Pharmas With Cash to Spend
April 30, 2025
 · 
5 min read
 · 
Annalee Armstrong
Mergers & acquisitions
Novartis Drops up to $1.7B to Bolster Oligo Pipeline With Regulus Buy
April 30, 2025
 · 
2 min read
 · 
Tristan Manalac